Drug Patent Expirations for Jan 5, 2017

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

MACUGEN (pegaptanib sodium)
Valeant Pharms Llc
Patent number: 6,011,020
Expiration Date: Jan 4, 2017

BYDUREON (exenatide synthetic)
Astrazeneca Ab
Patent number: 6,858,576
Expiration Date: Jan 6, 2017

BYDUREON PEN (exenatide synthetic)
Astrazeneca Ab
Patent number: 6,858,576
Expiration Date: Jan 6, 2017

BYETTA (exenatide synthetic)
Astrazeneca Ab
Patent number: 6,858,576
Expiration Date: Jan 6, 2017

PREVANTICS MAXI SWABSTICK (chlorhexidine gluconate; isopropyl alcohol)
Prof Dspls
Patent number: D 68,424
Expiration Date: Jan 7, 2017

LIPITOR (atorvastatin calcium)
Pfizer
Patent number: 5,969,156
Expiration Date: Jan 8, 2017

CADUET (amlodipine besylate; atorvastatin calcium)
Pfizer
Patent number: 5,969,156
Expiration Date: Jan 8, 2017

LIPTRUZET (atorvastatin calcium; ezetimibe)
Merck Sharp Dohme
Patent number: 5,969,156
Expiration Date: Jan 8, 2017

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2017 Biotechblog

   One Comment


Leave a Reply

%d bloggers like this: